Suppliers / Avara Liscate Pharmaceutical Services

Avara Liscate Pharmaceutical Services

Italy Updated 9 July 2026

Avara Liscate Pharmaceutical Services is a finished-dose manufacturer based in Italy. It appears in 6 regulatory filings across 4 regulators, without an active US DMF or CEP on file. Its filings concentrate with EDE (AE), NPRA (MY) and ARCSA (EC). Its GMP standing is certified by ANVISA (Brazil), EMA and MFDS (Korea), among 5 authorities. Its most recent recorded inspection, by US FDA, closed on 9 June 2023 as VAI.

0
active US DMFs
0
valid CEPs
4
registered plants 1 with an FDA FEI number
6
filings across 4 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
6 of 6 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 9 June 2023 VAI US FDA
  • 6 December 2022 VAI US FDA
  • 20 September 2019 VAI US FDA
  • 22 November 2016 VAI US FDA
  • 13 May 2014 OAI US FDA
  • 9 November 2011 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Milan, United Arab Emirates Not on file
LISCATE, Italy Not on file
Liscate, Italy Not on file
Italy, Italy 3004640070

Filings and GMP by regulator

Regulator Filings GMP certificates
EDE (AE) 2 None
NPRA (MY) 2 None
ARCSA (EC) 1 None
MINSA (CR) 1 None
ANVISA (Brazil) None 3
EMA None 2
MFDS (Korea) None 2
EAEU_EEC None 1
US FDA None 1

Questions about Avara Liscate Pharmaceutical Services

Does Avara Liscate Pharmaceutical Services hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Avara Liscate Pharmaceutical Services. It does have 6 filings with 4 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Avara Liscate Pharmaceutical Services FDA-registered?
One site operated by Avara Liscate Pharmaceutical Services carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Avara Liscate Pharmaceutical Services's last inspection go?
The most recent inspection on record closed on 9 June 2023 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 6 inspections are on file, of which 1 closed as OAI.
Where does Avara Liscate Pharmaceutical Services manufacture?
4 registered sites are on record, in United Arab Emirates and Italy (Milan, Liscate and Liscate among others). Every site is listed on this page with the register it came from.
Which regulators recognise Avara Liscate Pharmaceutical Services's GMP?
Current GMP certificates are on record from ANVISA (Brazil), EMA, MFDS (Korea), EEC (Eurasian Economic Union) and US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Avara Liscate Pharmaceutical Services comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 9 June 2023.

Comparable suppliers

A. Menarini Manufacturing Logistics And Services also in Italy Adienne also in Italy AlfaSigma also in Italy Aptuit also in Italy Biologici Italia Laboratories also in Italy

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates